CD19 Polyclonal Antibody

Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. CD19 encodes a cell surface molecule (CD19 molecule) which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.

The CD223 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CD223 protein expression in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human CD223 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards CD223 protein, making it an ideal tool for various research applications.

The CD223 Polyclonal Antibody is suitable for use in a variety of immunological techniques, including Western blotting, immunohistochemistry, and flow cytometry. It has been validated for use in human, mouse, and rat samples, and has been shown to detect CD223 protein expression in a variety of tissues and cell types. This antibody is supplied as a purified IgG fraction, and has been tested for purity and specificity to ensure optimal performance in downstream applications.

In summary, the CD223 Polyclonal Antibody is a reliable and high-quality reagent for the detection and quantification of CD223 protein expression in various biological samples. Its high specificity and sensitivity make it an ideal tool for researchers studying the role of CD223 in various physiological and pathological processes.